COVID-19: another reason for anticoagulation in patients with atrial fibrillation.

Raatikainen, Pekka; Lassila, Riitta

Raatikainen, Pekka; Lassila, Riitta.

Raatikainen P; Department of Cardiology, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland pekka.raatikainen@hus.fi.
Lassila R; Coagulation Disorders Unit, Department of Haematology, Comprehensive Cancer Center, Helsinki University Hospital, and Reserach Program Unit of Systems Oncology, University of Helsinki, Helsinki, Finland, Helsinki, Finland.

Heart ; 108(12): 902-904, 2022 05 25.

Article in English | MEDLINE | ID: covidwho-1752892

Subject(s)

Atrial Fibrillation; COVID-19; Stroke; Anticoagulants/adverse effects; Atrial Fibrillation/complications; Atrial Fibrillation/drug therapy; Blood Coagulation; Humans; Risk Factors

Keywords

COVID-19; atrial fibrillation; pharmacology, clinical; stroke

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Heart Journal subject: Cardiology Year: 2022 Document Type: Article Affiliation country: Heartjnl-2022-320845

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google